Quantcast

GI Monitor, Leading (IBD) Crohn’s and Colitis Mobile Tracking App from WellApps, Upgrades User-base and Platform as Creator Recovers from Surgery

June 14, 2011

UPPER SADDLE RIVER, N.J., June 14, 2011 /PRNewswire/ — WellApps, Inc. announced today the newest release of GI Monitor, its symptom tracking app for (IBD) Crohn’s and Ulcerative Colitis. Co-Founder Edward Shin, MD, says, “We’re particularly excited about the new release since GI Monitor has recently quadrupled its user-base. This scale is providing some powerful real-time data and we know what an engaged mobile community can mean for patients.” One of those patients is Brett Shamosh, creator of GI Monitor and Co-Founder of WellApps, who has a personal passion for the potential of mobile health. After twenty years with Ulcerative Colitis, Brett chose to undergo a colectomy to prevent colon cancer and is recovering in the hospital as GI Monitor’s newest features are being released. “Removing my colon was a very tough decision and I wanted to have more data at my fingertips when I made it. I’m hopeful that emerging mobile communication technologies will lead to better-informed decisions and improved quality of life.”

GI Monitor allows (IBD), Crohn’s and Colitis patients to easily track symptoms, share reports with their doctors and use interactive charts to make correlations between symptoms, diet and medications. The newest release includes an updated web-app that allows patients to compare their symptoms and medications to the averages within their diagnosis. Another new feature of the mobile apps is called “Photo Therapy”, which encourages users to share photos of things that make them smile.

GI Monitor is free to patients and is currently available in the iTunes Store, Android Market and at http://www.wellapps.com.

WellApps develops and distributes symptom tracking applications for patients with chronic illnesses. The data collected is compiled into easy-to-read reports for physicians, resulting in optimal patient treatment and reduced periods of active disease. Patients can also access interactive charts to see correlations between symptoms and understand how compliance to medication affects their well-being. De-identified data from our patient population is collected anonymously and shared with researchers to make progress in the treatment of chronic illnesses.

For more information: support@wellapps.com

This press release was issued through 24-7PressRelease.com. For further information, visit http://www.24-7pressrelease.com.

SOURCE WellApps, Inc.


Source: newswire



comments powered by Disqus